https://scholars.lib.ntu.edu.tw/handle/123456789/193150
標題: | Effects of Irradiated Tumor Vaccine and Infusion of Granulocyte- Macrophage Colony-Stimulating Factor and Interleukin-12 on Established Gliomas in Rats | 作者: | CHEN, JIN-CHERNG CHEN, YUN WU, JIANN-MING SU, YEN-HAO TAI, KUO-FENG TSENG, SHENG-HONG |
關鍵字: | glioma;immunotherapy;GM-CSF;IL-12;tumor vaccine | 公開日期: | 2006 | 卷: | v.55 | 期: | n.7 | 起(迄)頁: | 873-883 | 來源出版物: | CANCER IMMUNOLOGY IMMUNOTHERAPY | 摘要: | Purpose: We investigated granulocyte-macrophage colony- stimulating factor (GM-CSF) and interleukin-12 (IL-12) infused into the injection site of irradiated tumor vaccine( TV) as therapy for gliomas. Methods: Rats with subcutaneous RT-2 gliomas were treated with irradiated TV and/or subcutaneous infusion of GM-CSF and/or IL-12 via osmotic minipump 5 days after tumor-cell inoculation. Cytotoxic T lymphocyte (CTL) and natural killer (NK) cell activity were analyzed to investigate immune responses. Rats with intracerebral gliomas were treated with irradiated TV and infused GM-CSF/IL-12 3 days after tumor-cell inoculation. Tumor growth rates and animal survival were followed. Survivors were re-challenged with wild-type RT-2 cells subcutaneously or intracerebrally to study long-term anti- tumor immunity. Results: Rats with subcutaneous gliomas treated with GM-CSF and IL-12 or TV plus GM-CSF or IL-12 did not have increased survival rate (P > 0.2), but did have prolonged survival time (P < 0.05); in contrast, rats treated with TV plus GM-CSF/IL-12 had increased survival rate (P < 0.05) and prolonged survival time (P < 0.05) compared with controls. These treatment strategies showed enhanced CTL and NK cell activities. Rats with intra- cerebral gliomas treated with TV plus GM-CSF/ IL-12 did not have increased survival rate (P=0.11), but did have prolonged survival time (P < 0.0001). Survivors in each group were re- challenged with wild-type RT-2 cells, and all had long-term survival. Conclusions: Irradiated TV plus continuous localized infusion of GM-CSF/IL -12 may induce a tumor-specific anti-tumor immune response on established subcutaneous or intra-cerebral gliomas, and such a treatment strategy deserves consideration as adjuvant treatment for glioma. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/92891 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。